Following treatment with 90Y-NM600 RPT, mice bearing EL4 lymphoma tumors revealed not only an increased infiltration of CD8+ T cells in the TME but also a significant activation of these infiltrated CD8+ T cells (81). This evidence concerns the gene CD8A and lymphoma.